Why 70% Infertile Patients Prefer U.S. & Mexico IVF?

2026-03-13 09:45:42，浏览量： 1次

 

In China, infertility is becoming increasingly common, with prevalence rates approaching 12%-15%. Among these cases, female factors account for about half, male factors about 30%, and combined factors about 20%. Although domestic assisted reproductive technology has advanced rapidly, overall success rates still face challenges, leaving many families struggling to achieve pregnancy after repeated attempts. With the relaxation of policies allowing second and third children, the number of older prospective parents has surged, and overseas options such as U.S. and Mexico IVF are gaining attention. Surveys indicate that approximately 70% of infertile patients say they would prefer treatment in the U.S. or Mexico if conditions allow.

 

 Technological Leadership: Third-Generation Screening Reduces Risk

 

U.S. IVF technology has evolved from first-generation IVF and second-generation ICSI to third-generation PGS/PGD (now called IVF-PGT). This technology enables chromosomal screening of blastocysts, excluding abnormal embryos and significantly lowering miscarriage risk. Domestic technology has progressed, but there remains a gap in blastocyst culture success rates and screening precision. Many families choose U.S. and Mexico IVF precisely because they can obtain healthier embryos and improve live birth rates. Mexico's medical standards align with U.S. practices, and combining third-generation IVF-PGT screening offers greater hope for older prospective parents.

 

 Superior Medical Environment: Laboratory & Equipment Advantages

 

Laboratories in U.S. IVF hospitals maintain higher standards in sealing, sterility, and temperature control, enabling embryos to be cultured to the fifth-day blastocyst stage. This “extra two days” of culture makes a significant difference in post-transfer success rates. Some domestic hospitals still have room for improvement in blastocyst culture and embryo quality control. U.S. and Mexico IVF preparation combines these advantages: advanced laboratory equipment and experienced embryologists give prospective parents a sense of greater stability throughout the cycle.

 

 More Cautious Medication Management: Protecting Women's Health

 

U.S. specialists emphasize precise medication during stimulation to avoid ovarian hyperstimulation syndrome (OHSS) from excessive dosing. Some domestic hospitals pursue higher egg numbers with larger doses, increasing physical burden on women. In U.S. and Mexico IVF preparation, doctors dynamically adjust doses based on the patient's constitution, fully utilizing blastocyst culture technology to ensure both safety and effectiveness.

 

 More Flexible Legal Environment: Supporting Diverse Needs

 

The U.S. and Mexico have more open laws regarding assisted reproduction, supporting single and same-sex families in pursuing IVF. Domestic policies remain relatively restrictive, limiting many options. U.S. and Mexico IVF preparation offers greater possibilities, especially for couples with special family structures. Mexico's regulations are friendly to cross-border transport of frozen tissues, with transparent processes that allow prospective parents more freedom in planning reproduction.

In summary, the advantages of U.S. and Mexico IVF in technology, medical environment, medication management, and legal flexibility explain why 70% of infertile patients lean toward overseas treatment. Through personalized plans and professional support, preparation no longer relies on chance but becomes controllable.

 

For a couple working hard toward having a child, the insights from IVF USA and Dr. Nathan Zhang may offer clearer direction, helping you move steadily toward a complete family.